Navigation Links
Insomnia in Medical News

Meditation May Help Put Primary Insomnia to Bed

Deep relaxation techniques could be key to a restful night, study finds TUESDAY, June 9 (HealthDay News) -- If you're tossing and turning and having trouble getting a good night's sleep, you may want to consider meditation, researchers suggest. People with primary insomnia reported ...

In Some Insomnia Patients, Brain Just Won't Shut Down

Abnormal levels of a neurochemical are linked to sleep disorder, study finds TUESDAY, June 9 (HealthDay News) -- Adults with primary insomnia have a neurochemical abnormality that makes it difficult to "shut down" the mind at night for sleep, new research has found. Researchers me...

Ignoring Insomnia Costs America $42 Billion a Year

Research Paper Examines the Burdens of Insomnia and Potential Solutions NEW YORK, May 27 /PRNewswire-USNewswire/ -- Sanofi-aventis U.S., with research and support from The Center for Medicine in the Public Interest (CMPI), has released a report showing the lag in the diagnosis and treatment ...

AmericInn Hotels Kicks-Off 'Sleep Better America' With Launch of New Web Site to Educate Consumers About Insomnia and Sleep-Related Issues

CHANHASSEN, Minn., March 5 /PRNewswire/ -- AmericInn(R) International, LLC officially kicks off "Sleep Better America," the hotel chain's new sleep advocacy and awareness campaign, with the launch of http://www.sleepbetteramerica.net . The new Web portal is designed to educate consumers about sle...

Study finds behavioral link between insomnia and tension-type headaches

Using sleep or napping to cope with chronic pain caused by tension-type headaches could lead to chronic insomnia according to a new study by researchers at Rush University Medical Center. The study, published in the February 15 issue of the Journal of Clinical Sleep Medicin e, found that napping ...

Primary Insomnia Tied to Brain Neurochemical Imbalance

Finding suggests complaint of a 'racing mind' is not just in patient's head MONDAY, Nov. 3 (HealthDay News) -- Adults with primary insomnia have a specific neurochemical imbalance that makes it more difficult for their brains to settle down for sleep, a new study says. People with ...

Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults

Westchester, Ill. A study in the Nov. 1 issue of the journal Sleep is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia, providing greater insight to the limited understanding of the condition's pathology. Results indicate that gamma-aminobutyri...

Adolescent insomnia linked to depression and substance abuse during adolescence and young adulthood

Westchester, Ill. A study in the Oct. 1 issue of the journal Sleep shows that adolescent insomnia symptoms are associated with depression, suicide ideation and attempts, and the use of alcohol, cannabis and other drugs such as cocaine. Findings suggest that the presence of insomnia in adoles...

Moderate Aerobics May Ease Insomnia Symptoms

Brazilian study finds 36% reduction in time awake and a drop in anxiety levels THURSDAY, June 12 (HealthDay News) -- A session of moderate aerobic exercise can help reduce anxiety and improve the quality of sleep for insomnia patients, according to a Brazilian study. Heavy aerobic or m...

Parental Insomnia Can Harm Adolescent Children

Study finds these kids more likely to have insomnia, suicidal thoughts THURSDAY, June 12 (HealthDay News) -- Adolescent children of parents who suffer from chronic insomnia have a higher risk not only for insomnia themselves, but also for suicidal behavior and for using drugs that indu...

More>>

Insomnia in Medical Technology

HealthMedia and Aetna to Study Online Insomnia and Depression Interventions

Controlled Trial Conducted with Pilot Programs ANN ARBOR, Mich., June 19 /PRNewswire/ -- HealthMedia, Inc., the global leader in scalable behavior change interventions with outcomes, announced a new research study with Aetna which will provide HealthMedia's Overcoming(TM) Insomnia...

Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies

- APD125 Significantly Improved Key PSG Parameters of Sleep Maintenance - - Phase 2b Subjective Study Ongoing - SAN DIEGO, June 12 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today that Dr. Thomas Roth of Henry Ford Hospital presented data fr...

Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder

Ambien CR(R) 12.5 mg significantly improved sleep onset, sleep maintenance and total sleep time compared to placebo BRIDGEWATER, N.J., June 10 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today results from a new study that showed Ambien CR(R) (zolpidem tartrate extended-re...

New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV

Study Confirms Role of AMBIEN CR in Effectively Managing Insomnia to Improve Quantity and Quality of Work Performance BRIDGEWATER, N.J., Oct. 24 /PRNewswire-FirstCall/ -- Sanofi-aventis today announced results from a new study that showed patients with chronic insomnia who were tr...

Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

"Trial Concluded Early Due to Achievement of Statistical Significance Demonstrated at the Primary Endpoint" NEW YORK, Jan. 13 /PRNewswire/ -- Intra-Cellular Therapies, Inc. today announced successful top-line efficacy results for ITI-007 from a Phase II trial in Insomnia characterized by di...

Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia

SAN DIEGO, Dec. 9 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today announced preliminary data from a Phase 2b clinical trial of APD125 measuring subjective endpoints in patients with primary insomnia. The initial data analysis indicates that APD125 did not meet the tri...

Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia

Study Meets Primary Endpoint, with Positive Effect Sustained Through Duration of 4-Week Study ROCKVILLE, Md., June 26 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) (Vanda) today announced positive top-line results from a Phase III trial showing ...

Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia

SAN DIEGO, April 8, 2008 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today that it initiated screening in a Phase 2b clinical trial of APD125 in patients with primary insomnia. APD125 is an oral drug candidate discovered by Arena with the potential to reduc...

Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia

NEW YORK, Dec. 20 /PRNewswire/ -- Intra-Cellular Therapies, Inc. (ITI), today announced it has initiated a sleep maintenance insomnia (SMI) Phase 2 clinical study using its drug candidate ITI-722. ITI-722 acts predominantly as a selective 5-HT2A receptor antagonist and represents an important ...

Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia

SAN DIEGO, Sept. 25 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today announced positive preliminary results from its Phase 2 clinical trial of APD125 in patients with chronic insomnia. APD125 is an orally available drug candidate discovered by Arena that is being ev...

More>>

Insomnia in Medical Definition

Abtissue pathology

...ss/Insomnia Middle Stage: Twitching Restlessness/Insomnia Prone to cold/flu/disease Late Stage: Constant Restlessness Severe insomnia Full-Body Spasms Hyperventilating ...
Insomnia in Medical Dictionary

Insomnia

Insomnia is a symptom of any of several sleep disorders, characterized by persistent difficulty falling asleep or staying asleep despite the opportunity. Insomnia is a symptom, not a stand-alone diagnosis or a disease. By... Information about insomnia , its symptoms, causes, types, and t...

Sleeping difficulty

...ic difficulty sleeping are more than twice as likely ... to sleep difficulties include difficulty initiating and ... ... sleep phase insomnia is not a total lack of sleep , but rather a difficulty ... that can delay sleep time for several hours, or a difficulty staying asleep. ... ...

Sleep Disorders

...ion from the government and other organization resources. Sleep disorders can be managed once ... Sleep Disorders . Overview. Physician ... insomnia is the most common sleep disorder . It occurs more often in women ... Featuring clear descriptions of sleep disorders and treatments, the s...

Irritability

...is seen at the beginning of many infectious diseases, some ... Irritability is a common complaint and accompanies several medical disorders. ... insomnia results in irritability , fatigue, decreased concentration, and often ... Free reference information from The NY Times on symptoms and their caus...

Hypnotics

... Hypnotic drugs are a class of psychoactives whose primary function is to induce sleep and to be used in the treatment of insomnia and in surgical anesthesia. Because drugs in this class generally produce dose-dependent effects, ranging from anxiolysis to production of... ( H...

Hypnotic

... Hypnotic drugs are a class of psychoactives whose primary function is to induce sleep and to be used in the treatment of insomnia and in surgical anesthesia. Because drugs in this class generally produce dose-dependent effects, ranging from anxiolysis to production of... Hyp...
Insomnia in Biological News

Study on origin of mutation that causes fatal familiar insomnia

This release is available in Spanish . A PhD thesis at the University of the Basque Country (UPV/EHU) has studied the origin of the mutation that causes Fatal Familiar Insomnia (FFI). In the Autonomous Community of the Basque Country there is a high rate of carriers of this mutation 50%...

Studies suggest new brain protein may help in treating schizophrenia, insomnia and anxiety

A small protein in the brain that has only recently been discovered and, paradoxically, induces both profound wakefulness and a less anxious state, may represent a novel target for the treatment of psychotic behavior and schizophrenia, according to new research presented at the 6th International Co...

New cardiology research presented at CHEST 2008

...bosentan therapy for patients with PAH. #6480 insomnia DOES NOT PREDICT HIGH BLOOD PRESSURE (Tuesday, O...niversity of Kentucky proposed the hypothesis that insomnia would predict hypertension, particularly among Afr...an over a 6-year period of follow up. Furthermore, insomnia complaints did not predict hypertension in women o...

Light receptors in eye play key role in setting biological clock, study shows

...se find it hard to stay alert at night while on the job. An estimated one in six people in the United States suffer from sleep disorders, including insomnia and excessive sleepiness. And as the U.S. population ages, a growing number of people are developing visual impairments that can result in sleep disor...

Gene mutations in mice mimic human-like sleep disorder, UT Southwestern researchers find

... DALLAS May 20, 2008 Mutations in two genes that control electrical excitability in a portion of the brain involved in sleep create a human-like insomnia disorder in mice, UT Southwestern Medical Center researchers have found. The findings may help scientists better understand the disorder and provide a...

Journal Sleep: Insomniacs are more likely to report a family history of the sleep disorder

...TER, Ill. Individuals with either current or past insomnia are more likely to report a family history of insomnia than are those who have never had the sleep disord...as good sleepers, 32.5 percent as individuals with insomnia symptoms, and 15.5 percent as having met criteria ...

'Night owls' report more insomnia-related symptoms

... insomnia. Compared to the morning and intermediate types, people with insomnia who prefer evening activities (i.e., “night owls? reported the most sleep/w...the ‘night owl?group,?said Ong. “These factors may serve to perpetuate the insomnia disorder, and might be particularly important to consider when treating thi...
Insomnia in Biological Technology

Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly Patients

SEATTLE, June 11 /PRNewswire/ -- Neurim Pharmaceuticals ( http://www.neurim.com ) presented today the preliminary results of a large-scale Phase III study of Circadin(R) 2mg, prolonged release melatonin in insomnia, demonstrating long term efficacy and safety in elderly patients. The results w...

Controversial Study to Test Link Between Insomnia and Sleep Apnea

Measuring Prevalence of Sleep Apnea Among Insomnia Patients ALBUQUERQUE, N.M., Feb. 9 /PRNewswire/ -- The Sleep and Human Health Institute (SHHI) was awarded a grant to study one of the most controversial aspects of Chronic Insomnia. Conventional wisdom connects insomnia to psychological fact...

Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel

CEO Glenn A. Oclassen to Join Sleep Experts in Panel Hosted by Natixis Bleichroeder PT. RICHMOND, Calif., Oct. 1 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, President and Chief Executive Officer, will participate in a pa...

Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201

Very Robust Findings on the Key Problems Faced by Insomniacs, i.e. Sleep Onset and Sleep Maintenance Evotec to Host a Conference Call Today at 11:00 am CET (10:00 am UK time, 5:00 am EST, 7:00 pm AEST) Directly From the Worldsleep07 Congress in Australia HAMBURG, Germany and OXFORD, England,...

Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia

HAMBURG, Germany and OXFORD, England, August 28 /PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT) is pleased to invite you to a webcast presentation and conference call on detailed Phase II data for its lead compound EVT 201 in the treatment of insomnia on 5 September 2007 at...

Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

'Trial Meets Primary and Key Secondary Endpoints' NEW YORK, March 10 /PRNewswire/ -- Intra-Cellular Therapies, Inc. today announced the final results from the ITI-007 Phase II trial in patients with Sleep Maintenance Insomnia (SMI). In this study, ITI-007 significantly and dose-dependently i...

Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting

...imelteon at APA. Tasimelteon is an investigational compound in development for the treatment of circadian rhythm sleep disorders, including transient insomnia caused by jet lag. The following two posters discussing data from Fanapt(TM) clinical trials will be presented at scientific poster sessions on M...

Mylan Confirms Four First-to-File Challenges

... New Jersey in connection with the ANDA filing for Eszopiclone Tablets, 1 mg, 2 mg and 3 mg. Eszopiclone Tablets are the generic version of Sepracor's insomnia treatment Lunesta(R) Tablets, which had approximately $796 million in U.S. sales for the twelve months ending Dec. 31, 2008, according to IMS Health. ...

FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout

...iaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia and gastroenterology treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabet...

FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD

...iaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia and gastroenterology treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabet...
Insomnia in Biological Definition

Prion

... (vCJD, nvCJD) Humans BSE prion* BovPrP Sc * Gerstmann-Strussler-Scheinker syndrome (GSS) Humans GSS prion HuPrP Sc Fatal familial insomnia (FFI) Humans FFI prion HuPrP Sc * or variant Fungal prion Protein Natural host Prion name Ure2p Saccharomyces...
Other Tags
(Date:11/24/2014)... (PRWEB) November 24, 2014 Global ... 6.19 billion by 2020, according to a new ... rates of cardiac arrhythmias clubbed with growing global ... this market. Though still in the budding stage, ... rise in usage rates in the recent times, ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 A ... , London's pre-eminent pain-relief service and massage therapy ... Sports Massage (ESM). This newest sports massage ... The key difference between traditional sports massage and ... access the body's very own "reset button,” and ...
(Date:11/24/2014)... Raymond, Alberta (PRWEB) November 24, 2014 ... of people each day. They break up families, ... there is new hope for those that suffer,” ... “Ground-breaking scientific research is showing that our specialized ... , Hardy will appear on “Mind Over Matter”, ...
(Date:11/24/2014)... November 24, 2014 Dr. Michael Kettel ... Center, recently appeared on NBC to discuss egg freezing as ... has been trending in the news recently, with new company ... for women. , “[The companies] see it as ... on a career hot path.” Says Dr. Kettel. , Up ...
(Date:11/23/2014)... 2014 The report, “Market Snapshot: ... 2020 - Asia-Pacific” provides quantitative analysis of the ... minimally invasive body contouring devices, non-invasive body contouring ... market size data by revenue and volume over ... China, Japan, South Korea, Australia and India. It ...
Breaking Medicine News(10 mins):Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 3Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 4Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 2Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 3Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4
(Date:11/21/2014)... 2014  Earlier this year Donald Spector , ... one of the most prolific inventors in the world, ... from Smartphones to third party agencies. Spector envisioned this ... of the earliest known patents in this area. Now ... military, child care, elder care and hospital applications. This ...
(Date:11/21/2014)... 20, 2014   Atmel® Corporation (NASDAQ: ... and touch technology solutions, today launched the industry,s first ... the widest V cc range from 1.7V to ... faster I 2 C bus communication speeds, and are ... making them ideal for consumer, industrial, computer, and medical ...
(Date:11/18/2014)... Nov. 17, 2014 The Parenteral Drug Association (PDA) ... agencies will speak and at least seven more will participate ... the Omni Shoreham Hotel in Washington D.C. ... to have significant support from the regulatory agencies in ... in our effort to help advance the use ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
Other Contents